Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Not yet recruiting × Prednisolone × Clear all

Phase

Phase 3 2 Phase 1/2 2 Phase NA 1 Phase 4 1 Phase 2 1

Status

Completed 11 Withdrawn 1 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1 Adrenal Insufficiency 1

Interventions

anlotinib 5 lenvatinib 4 Oxaliplatin 4 Carboplatin 4 Prednisone 3 Immune Checkpoint Inhibitors 3 Dexmedetomidine 3 Dexamethasone 3 Cisplatin 3 venetoclax 2 sintilimab 2 Rosuvastatin Calcium 2 Leucovorin 2 Injections 2 Indocyanine Green 2 Fluorouracil 2 Cyclophosphamide 2 Capecitabine 2 Bevacizumab 2 Aspirin 2 zanubrutinib 1 xiaojin wan 1 trastuzumab deruxtecan 1 trametinib 1 tislelizumab 1 testosterone 17 beta-cypionate 1 tenofovir alafenamide 1 telitacicept 1 talquetamab 1 talniflumate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡